 |
市场调查报告书
商品编码
1491747
週边干预市场规模、份额、成长分析、按产品、按应用、按最终用途 - 行业预测，2024-2031 年Peripheral Interventions Market Size, Share, Growth Analysis, By Product(Catheters, Sheath), By Application(Venous Thromboembolism, Peripheral Artery Disease), By End-Use(Hospitals, Ambulatory Surgical Centres) - Industry Forecast 2024-2031 |
||||||
2022年全球外围干预市场规模为86.8亿美元，从2023年的94.2亿美元成长到2031年的180.9亿美元，预测期间（2024-2031年）预计复合年增长率为8.50%。
高血压、糖尿病、肥胖、吸烟和高碳水化合物饮食等因素会导致多种心血管疾病。这种健康问题导致导管实验室（cath labs）在全球范围内激增，特别是在新兴市场，随着专门从事外周干预的医疗保健专业人员的增加，正在推动行业增长。导管实验室在心血管疾病的诊断和治疗中发挥重要作用，其使用正在增加，特别是在开发中国家，而混合导管实验室的出现代表了最近的一项重要进展。这些可以进行心臟和周边干预以及神经、电生理和其他临床手术的混合设施正在增加。特别是在印度，随着包括血管成形术在内的周边干预措施的普及，导管实验室的数量显着增加，从而推高了全球医疗保健支出。随着此类手术需求的持续增长，专家和导管实验室的扩张预计将进一步推动产业成长。
目录
介绍
- 这项研究的目的
- 定义
- 市场范围
调查方法
- 资讯采购
- 二手资料来源和主要资料来源
- 市场规模预测
- 市场危机与限制
执行摘要
- 市场概况展望
- 供需趋势分析
- 按细分市场的机会分析
市场动态及展望
- 市场动态
- 促进因素
- 机会
- 抑制因素
- 任务
- 波特的分析
主要市场考察
- 专利分析
- 市场生态系统
- 监管环境
- 创新矩阵
- 主要投资分析
- 关键成功因素
- 竞争程度
依产品：外围干预市场
- 市场概况
- 导管
- 鞘套
- 支架
- 裸金属支架
- 药物释放型支架
- 导管导引线
- 斑块切除装置
- 栓塞装置
- 血栓清除装置
- 下腔静脉过滤器
- 其他的
按应用：外围介入市场
- 市场概况
- 静脉血栓栓塞症
- 周边动脉疾病
- 其他的
按应用：外围介入市场
- 市场概况
- 医院
- 门诊手术中心
- 导管实验室
- 其他的
按地区划分：週边干预市场
- 市场概况
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区
竞争格局
- 前5名企业对比
- 主要企业市场定位（2023年）
- 主要市场参与者所采取的策略
- 近期市集活动
- 主要企业市场占有率（2023年）
主要企业简介
- Johnson & Johnson（United States）
- Medtronic（United States）
- Becton Dickinson（United States）
- Boston Scientific Corporation（United States）
- Abbott Laboratories（United States）
- Terumo Corporation（Japan）
- Cook Medical（United States）
- Cardinal Health（United States）
- CR Bard（United States）
- Teleflex Incorporated（United States）
- AngioDynamics Inc.（United States）
- B. Braun Melsungen AG（Germany）
- Asahi Intecc Co., Ltd.（Japan）
- Penumbra, Inc.（United States）
- Stryker Corporation（United States）
- Terumo Interventional Systems（United States）
- Olympus Corporation（Japan）
- Nipro Corporation（Japan）
- Endologix Inc.（United States）
- Merit Medical Systems, Inc.（United States）
Global Peripheral Interventions Market size was valued at USD 8.68 billion in 2022 and is poised to grow from USD 9.42 billion in 2023 to USD 18.09 billion by 2031, growing at a CAGR of 8.50% during the forecast period (2024-2031).
The escalating prevalence of cardiovascular disorders (CVD) is becoming a major driver for demand in peripheral interventions, fueled by factors like hypertension, diabetes, obesity, smoking, and diets rich in carbohydrates contributing to various CVD types. This health concern has led to a proliferation of catheterization laboratories (cath labs) globally, especially in emerging markets, accompanied by a rise in healthcare professionals specializing in peripheral interventions, thus bolstering industry growth. Cath labs play a vital role in diagnosing and treating cardiovascular conditions, with their utilization increasing, particularly in developing nations, and the advent of hybrid cath labs marking a significant recent advancement. These hybrid facilities, adaptable for cardiac and peripheral interventions as well as neurological, electrophysiological, and other clinical procedures, are on the rise. Notably, India has seen a substantial increase in cath lab numbers, accompanied by a significant surge in peripheral intervention procedures, including angioplasties, consequently driving up global healthcare expenditure. With a projected continued rise in demand for these procedures, the expansion of specialized experts and catheterization laboratories is expected to further propel industry growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Interventions Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Peripheral Interventions Market Segmental Analysis
The global peripheral interventions market is segmented on the basis of product, application, end-use, and region. By product, the market is segmented into catheters, sheath, stents, bare-metal stents, drug-eluting stents, guide wires, atherectomy devices, embolic devices, thrombectomy devices, IVC filters and others. By application, the market is segmented into venous thromboembolism, peripheral artery disease and others. By end-use, the market is segmented into hospitals, ambulatory surgical centers, catheterization laboratories and others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
Drivers of the Global Peripheral Interventions Market
The increasing frequency of cardiovascular disorders, encompassing conditions like peripheral artery disease (PAD), is fueling the demand for solutions targeting peripheral health. This surge in cardiovascular issues is mainly linked to risk factors such as hypertension, diabetes, obesity, and a sedentary lifestyle.
Restraints in the Global Peripheral Interventions Market
Limited market accessibility stems from the high costs associated with peripheral intervention treatments for certain individuals, potentially hindering access to essential care, particularly in affluent regions with expensive healthcare systems.
Market Trends of the Global Peripheral Interventions Market
The rising demand for invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures, is driving the growth of hybrid catheterization labs, which are becoming increasingly popular. This expanding market is fueled by the versatility and adaptability of these facilities.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Patent Analysis
- Ecosystem of the Market
- Regulatory Landscape
- Innovation Matrix
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Peripheral Interventions Market by Product
- Market Overview
- Catheters
- Sheath
- Stents
- Bare-meta Stents
- Drug-eluting Stents
- Guide Wires
- Atherectomy Devices
- Embolic Devices
- Thrombectomy Devices
- IVC Filters
- Others
Peripheral Interventions Market by Application
- Market Overview
- Venous Thromboembolism
- Peripheral Artery Disease
- Others
Peripheral Interventions Market by End-use
- Market Overview
- Hospitals
- Ambulatory Surgical Centres
- Catheterization Laboratories
- Others
Peripheral Interventions Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton Dickinson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- C. R. Bard (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AngioDynamics Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Asahi Intecc Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Interventional Systems (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Endologix Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merit Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
